ZA946767B - Monocional antibodies having property of causing apoptosis. - Google Patents

Monocional antibodies having property of causing apoptosis.

Info

Publication number
ZA946767B
ZA946767B ZA946767A ZA946767A ZA946767B ZA 946767 B ZA946767 B ZA 946767B ZA 946767 A ZA946767 A ZA 946767A ZA 946767 A ZA946767 A ZA 946767A ZA 946767 B ZA946767 B ZA 946767B
Authority
ZA
South Africa
Prior art keywords
antibody
property
myelocytic
causing apoptosis
apoptosis
Prior art date
Application number
ZA946767A
Other languages
English (en)
Inventor
Naoshi Fukushima
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of ZA946767B publication Critical patent/ZA946767B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ZA946767A 1993-09-03 1994-09-02 Monocional antibodies having property of causing apoptosis. ZA946767B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP05242110 1993-09-03

Publications (1)

Publication Number Publication Date
ZA946767B true ZA946767B (en) 1995-04-03

Family

ID=17084452

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA946767A ZA946767B (en) 1993-09-03 1994-09-02 Monocional antibodies having property of causing apoptosis.

Country Status (19)

Country Link
US (4) US5840344A (de)
EP (1) EP0721015B1 (de)
KR (1) KR100241863B1 (de)
CN (1) CN1046314C (de)
AT (1) ATE280835T1 (de)
AU (1) AU692466B2 (de)
CA (1) CA2169950A1 (de)
CZ (1) CZ294359B6 (de)
DE (1) DE69434097T2 (de)
FI (1) FI960567A7 (de)
HU (1) HU222989B1 (de)
NO (1) NO960684L (de)
PL (1) PL181783B1 (de)
RU (1) RU2202615C2 (de)
SK (1) SK281964B6 (de)
TW (1) TW426687B (de)
UA (1) UA50708C2 (de)
WO (1) WO1995006748A1 (de)
ZA (1) ZA946767B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006748A1 (en) * 1993-09-03 1995-03-09 Chugai Seiyaku Kabushiki Kaisha Monoclonal antibody that induces apoptosis
WO1997032601A1 (fr) * 1996-03-06 1997-09-12 Chugai Seiyaku Kabushiki Kaisha Procede de criblage de substances induisant l'apoptose
WO1998002543A1 (fr) 1996-07-15 1998-01-22 Chugai Research Institute For Molecular Medicine, Inc. Nouveaux facteurs analogues au vegf
US7531643B2 (en) * 1997-09-11 2009-05-12 Chugai Seiyaku Kabushiki Kaisha Monoclonal antibody inducing apoptosis
WO1999012973A1 (en) * 1997-09-11 1999-03-18 Chugai Seiyaku Kabushiki Kaisha Monoclonal antibody inducing apoptosis
WO2000053634A1 (en) * 1999-03-10 2000-09-14 Chugai Seiyaku Kabushiki Kaisha Single-stranded fv inducing apoptosis
US7696325B2 (en) * 1999-03-10 2010-04-13 Chugai Seiyaku Kabushiki Kaisha Polypeptide inducing apoptosis
US20040058393A1 (en) * 2000-04-17 2004-03-25 Naoshi Fukishima Agonist antibodies
EP2351838A1 (de) * 2000-10-20 2011-08-03 Chugai Seiyaku Kabushiki Kaisha Vernetzende, agonistische Antikörper
RU2287534C2 (ru) 2000-10-20 2006-11-20 Тугаи Сейяку Кабусики Кайся Деградированное антитело, являющееся агонистом tpo
US7195771B1 (en) 2000-11-21 2007-03-27 Kimberly-Clark Worldwide, Inc. Water-soluble lotions for paper products
AU2002361642A1 (en) * 2001-11-16 2003-06-10 The University Of Tennessee Research Corporation Recombinant antibody fusion proteins and methods for detection of apoptotic cells
US8158385B2 (en) 2002-10-11 2012-04-17 Chugai Seiyaku Kabushiki Kaisha Cell death-inducing agent
JP2004279086A (ja) * 2003-03-13 2004-10-07 Konica Minolta Holdings Inc 放射線画像変換パネル及び放射線画像変換パネルの製造方法
EP1609803A4 (de) * 2003-03-31 2006-05-24 Chugai Pharmaceutical Co Ltd Modifizierter antikörper gegen cd22 und anwendungen dafür
US20070280951A1 (en) * 2003-12-12 2007-12-06 Naoki Kimura Cell Death Inducing Agents
TW200530266A (en) * 2003-12-12 2005-09-16 Chugai Pharmaceutical Co Ltd Method of reinforcing antibody activity
JPWO2005056602A1 (ja) * 2003-12-12 2008-03-06 中外製薬株式会社 アゴニスト活性を有する改変抗体のスクリーニング方法
TW200530269A (en) 2003-12-12 2005-09-16 Chugai Pharmaceutical Co Ltd Anti-Mpl antibodies
RU2280461C2 (ru) * 2004-05-13 2006-07-27 Галина Викторовна Яровенко Способ лечения острого и хронического лимфатического отека конечностей
JP5057967B2 (ja) 2005-03-31 2012-10-24 中外製薬株式会社 ｓｃ（Ｆｖ）２構造異性体
JPWO2006123724A1 (ja) * 2005-05-18 2008-12-25 国立大学法人徳島大学 抗ｈｌａ抗体を利用した新規医薬品
KR101367544B1 (ko) 2005-06-10 2014-02-26 추가이 세이야쿠 가부시키가이샤 메글루민을 함유하는 단백질 제제의 안정화제, 및 그의이용
KR101360671B1 (ko) 2005-06-10 2014-02-07 추가이 세이야쿠 가부시키가이샤 ｓｃ（Ｆｖ）２를 함유하는 의약조성물
US20080038237A1 (en) * 2006-02-28 2008-02-14 Sapolsky Robert M Trojan horse immunotherapy
CN101517075A (zh) * 2006-07-13 2009-08-26 中外制药株式会社 细胞死亡诱导剂
CL2008000719A1 (es) * 2007-03-12 2008-09-05 Univ Tokushima Chugai Seiyaku Agente terapeutico para cancer resistente a agentes quimioterapeuticos que comprende un anticuerpo que reconoce hla de clase i como ingrediente activo; composicion farmaceutica que comprende dicho anticuerpo; y metodo para tratar cancer resistente a
WO2016090337A1 (en) 2014-12-05 2016-06-09 Memorial Sloan-Kettering Cancer Center Chimeric antigen receptors targeting fc receptor-like 5 and uses thereof
KR20180089497A (ko) 2015-12-04 2018-08-08 메모리얼 슬로안-케터링 캔서 센터 Fc 수용체-유사 5를 표적화하는 항체 및 사용 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006748A1 (en) * 1993-09-03 1995-03-09 Chugai Seiyaku Kabushiki Kaisha Monoclonal antibody that induces apoptosis
WO1997032601A1 (fr) * 1996-03-06 1997-09-12 Chugai Seiyaku Kabushiki Kaisha Procede de criblage de substances induisant l'apoptose
WO1999012973A1 (en) * 1997-09-11 1999-03-18 Chugai Seiyaku Kabushiki Kaisha Monoclonal antibody inducing apoptosis
WO2000053634A1 (en) * 1999-03-10 2000-09-14 Chugai Seiyaku Kabushiki Kaisha Single-stranded fv inducing apoptosis

Also Published As

Publication number Publication date
US5840344A (en) 1998-11-24
HU222989B1 (hu) 2004-01-28
HUT74594A (en) 1997-01-28
US6267959B1 (en) 2001-07-31
CN1130405A (zh) 1996-09-04
CA2169950A1 (en) 1995-03-09
US6759043B2 (en) 2004-07-06
RU2202615C2 (ru) 2003-04-20
FI960567L (fi) 1996-02-07
FI960567A0 (fi) 1996-02-07
ATE280835T1 (de) 2004-11-15
NO960684D0 (no) 1996-02-21
AU7546694A (en) 1995-03-22
AU692466B2 (en) 1998-06-11
EP0721015B1 (de) 2004-10-27
DE69434097T2 (de) 2006-02-02
PL181783B1 (pl) 2001-09-28
PL313260A1 (en) 1996-06-24
CZ61796A3 (en) 1996-06-12
KR100241863B1 (ko) 2000-03-02
UA50708C2 (uk) 2002-11-15
WO1995006748A1 (en) 1995-03-09
CN1046314C (zh) 1999-11-10
EP0721015A4 (de) 1999-03-31
CZ294359B6 (cs) 2004-12-15
NO960684L (no) 1996-02-21
US20010001712A1 (en) 2001-05-24
US20030147894A1 (en) 2003-08-07
SK281964B6 (sk) 2001-09-11
EP0721015A1 (de) 1996-07-10
SK25596A3 (en) 1996-10-02
FI960567A7 (fi) 1996-02-07
TW426687B (en) 2001-03-21
HU9600206D0 (en) 1996-03-28
DE69434097D1 (de) 2004-12-02

Similar Documents

Publication Publication Date Title
ZA946767B (en) Monocional antibodies having property of causing apoptosis.
NO961151D0 (no) Antistoffer mot CD40
DE69221147D1 (de) Nicht glycosylierter Anti-CD3-IgG-Antikörper
NO2006008I1 (no) Natalizumab, anti alfa-4 integrin humanized monoclonal antibody
MX9603080A (es) Anticuerpos monoclonales inmuno-estimulantes.
EP0222998A3 (en) Monoclonal antibodies and methods for fungal patthogen detection
FI973484A0 (fi) Menetelmä immuunivasteen stimuloimiseksi
CA2185112A1 (en) Humanized monoclonal antibodies against human interleukin-4
ATE206621T1 (de) Il-8 antagonisten zur behandlung von asthma
DE3580482D1 (de) Monoklonale antikoerper und immunisierung damit.
EP0287397A3 (en) Monoclonal antibody specific to human pancreatic phospholipase a2
DK49291D0 (da) Gramnegativ-bakterieendotoxinblokerende, monoklonale antistoffer
DE3785795D1 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
AU1493995A (en) Monoclonal antibody
NO172549C (no) Monoklonalt humanurokinase-antistoff, immunoabsorberende middel for rensing av humanurokinase samt anvendelse av antistoffet for detektering av humanurokinase
ITRM920223A0 (it) Anticorpi monoclonali anti-idiopici diretti contro anticorpi anti-tnf.
FI960566A7 (fi) Monoklonaalinen vasta-aine, joka tunnistaa välisolun pinta-antigeenin
DE69118702D1 (de) Neue verwendung eines monoklonalen antikörpers
AU6162794A (en) Carcinoma associated antigen (ng1) monoclonal antibodies against ng1, methods of producing these antibodies and use therefor
ATE58173T1 (de) Monoklonale antikoerper und immunisierung damit.
AU8819391A (en) Antibody reactive to hamster immunoglobulins